Risk of cardiovascular serious adverse events associated with varenicline use for tobacco cessation

To examine the risk of treatment emergent, cardiovascular serious adverse events associated with varenicline use for tobacco cessation. Meta-analysis comparing study effects using four summary estimates. Medline, Cochrane Library, online clinical trials registries, and reference lists of identified articles. Judith Prochaska, PhD, MPH, is Associate Professor in the Department of Medicine at Stanford University with the Stanford Prevention Research Center.

Publication

 

Image courtesy of interviewee. December 15, 2017

Log-in or Sign-up to Faculti
Currently viewing this subject insight as a guest. You have insight(s) remaining for this month.

Leave a Reply

Your email address will not be published. Required fields are marked *

Copyright © Faculti Media Limited 2013 - 2024. All rights reserved.
error: